FDA Declines to Approve of Epinephrine Alternative to EpiPen

The FDA's announcement requesting further study represents a step back in the process of 'neffy' becoming the first needle-free nasal spray epinephrine alternative.

Related Keywords

Richard Lowenthal , Grossig David Dworaczyk , Advisory Committee Votes In Support Of Favorable , Allergy Drug Advisory Committee , Drug Administration , Advisory Committee , Complete Response Letter , New Drug , Formal Dispute Resolution Request , New Drug Application , Committee Votes , Favorable Benefit Risk Profile , Allergic Reactions , Including Anaphylaxis , Published May , Epinephrine Nasal , Neffy , Fda , Fda Rejects , Crl , Epinephrine , Epipen , Allergy , Anaphylaxis ,